Background
ESKAPEEc contribute to a majority of bloodstream infections (BSIs) and their antibiogram have changed overtime, while data concerning about these alterations are lacking in China. Added that a paucity of studies referred to ESKAPEEc in pediatric BSIs, our study aimed to demonstrate the longitudinal alterations of ESKAPEEc distribution and antibiogram in adult and pediatric BSIs in Southwest China.
Methods
A multicenter retrospective surveillance study was launched from 2012 to 2017. Data of China Antimicrobial Resistance Surveillance System (CARSS) was analyzed by Whonet 5.6 and Graphpad Prism 6 Software.
Chi-square
test or
Fisher’s
exact test was used to examine and compare temporal changes.
Results
A total of 32,259 strains was isolated, with 17.4% from pediatric BSIs. ESKAPEEc contributed to 58.67% (18,924/32,259) of BSIs, with 65.3% of adult BSIs and 27.2% of pediatric BSIs.
Escherichia coli
(
E. coli
) and
Klebsiella pneumoniae
(
K. pneumoniae
) were the two predominant species. Carbapenem resistance was prevalent in 0.76, 4.60, 9.47,13.66, 59.47% of
E. coli
,
K. pneumoniae
,
Enterobacter cloacae
,
Pseudomonas aeruginosa
(
P. aeruginosa
) and
Acinetobacter baumannii
(
A. baumannii
), respectively. The proportions of methicillin-resistant
Staphylococcus aureus
(MRSA) and vancomycin-resistant
Enterococcus faecium
(VREFM) were 28.91% and 2.20%, respectively. Between 2012-2014 and 2015–2017,
E. coli
and
K. pneumonia
showed significantly increased resistance rates to imipenem but decreased to ceftriaxone and ceftazidime, while
A. baumannii
exhibited reduced resistances to almost all the beta-lactams tested. The prevalence of antimicrobial resistance to most of agents against Gram-positive ESKAPEEc did not significantly varied during the same timeframe. In comparison with those from adult BSIs,
K. pneumoniae
from pediatric BSIs exhibited high resistance rates to all the beta-lactams tested, especially to carbapenems (12.79% vs 3.87%), while
A. baumannii
showed low resistance rates to all the agents.
Conclusions
Ongoing burden of ESKAPEEc in BSIs and increasing trend of imipenem resistance in
E. coli
and
K. pneumoniae
call for continued surveillance. Carbapenems are still active against Gram-negative ESKAPEEc, except for
A. baumannii
and vancomycin or linezolid is still effective against Gram...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.